Brighton Jones LLC’s Boston Scientific BSX Stock Holding History

Brighton Jones LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Buy	55,109 +8,121	+17%	+$441K	0.04%	261
2026 Q1	$2.95M	Buy	+46,988	New	+$3.76M	0.07%	209
2025 Q4	–	Sell	-28,559	Closed	-$2.79M	–	173
2025 Q3	$2.79M	Sell	28,559 -3,282	-10%	-$340K	0.07%	166
2025 Q2	$3.42M	Buy	31,841 +4,377	+16%	+$443K	0.09%	129
2025 Q1	$2.77M	Buy	27,464 +88	+0.3%	+$8.86K	0.09%	131
2024 Q4	$2.45M	Buy	27,376 +226	+0.8%	+$19.9K	0.07%	144
2024 Q3	$2.28M	Buy	27,150 +10,132	+60%	+$799K	0.09%	121
2024 Q2	$1.31M	Buy	17,018 +12,091	+245%	+$885K	0.04%	196
2024 Q1	$337K	Buy	4,927 +574	+13%	+$36.9K	0.01%	434
2023 Q4	$252K	Buy	4,353 +354	+9%	+$18.9K	0.01%	479
2023 Q3	$211K	Buy	3,999 +205	+5%	+$10.8K	0.01%	488
2023 Q2	$205K	Buy	+3,794	New	+$198K	0.01%	503

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brighton Jones LLC's BSX Position: Q2 2026 in Review

Brighton Jones LLC increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $441K and bringing the position to 55,109 shares worth $2.35M. The position accounts for 0.04% of the portfolio, ranked #261.

Brighton Jones LLC first reported a position in BSX in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.42M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Brighton Jones LLC held 55,109 shares of Boston Scientific worth $2.35M as of Q2 2026.
Brighton Jones LLC bought 8,121 Boston Scientific shares in Q2 2026, an estimated $441K.
Boston Scientific made up 0.04% of Brighton Jones LLC's portfolio in Q2 2026, its #261 holding.
Brighton Jones LLC first reported a position in Boston Scientific in Q2 2023 and has held it in 12 quarters since.
Brighton Jones LLC's Boston Scientific position peaked at $3.42M in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.